A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver

计划入组 20 人 · 首次发布于 2016 年 11 月 17 日

Uncut Roux-en-Y vs Roux-en-Y

计划入组 84 人 · 首次发布于 2017 年 11 月 21 日

Benefit of Roux-en-Y (R-Y) Reconstruction After Pancreaticoduodenectomy

计划入组 40 人 · 首次发布于 2009 年 5 月 21 日

Target-Y modulator therapy(Golgi Neurosciences)

Target-Y modulator (multiple sclerosis/amyotrophic lateral sclerosis)

Y-8

Target Corporation

United States

Target Pharmasolutions, Inc.

United States

TARGET CORPORATION INDIA PRIVATE LIMITED

India

Clinical Trials Advance Novel Treatments for Androgenetic Alopecia as Researchers Target 30-Year Treatment Gap

Insilico Medicine Nominates AI-Designed ISM9077 as First-in-Class Preclinical Candidate for Ocular and Inflammatory Diseases

Y-mAbs Announces Strategic Realignment and Positive Preliminary Data for SADA PRIT Platform